DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,565,221 | +4.3% | 26,462 | +0.9% | 0.13% | +10.3% |
| Q2 2023 | $6,294,960 | +217.7% | 26,229 | +233.7% | 0.12% | +190.0% |
| Q1 2023 | $1,981,286 | +94789.2% | 7,861 | -0.1% | 0.04% | -36.5% |
| Q4 2022 | $2,088 | -99.9% | 7,866 | -0.2% | 0.06% | -6.0% |
| Q3 2022 | $2,037,000 | -25.0% | 7,885 | -26.4% | 0.07% | -30.2% |
| Q2 2022 | $2,715,000 | +43.7% | 10,708 | +66.2% | 0.10% | +31.5% |
| Q1 2022 | $1,889,000 | -20.1% | 6,441 | -10.3% | 0.07% | -20.7% |
| Q4 2021 | $2,363,000 | +0.6% | 7,181 | -7.0% | 0.09% | -17.9% |
| Q3 2021 | $2,350,000 | -3.6% | 7,718 | -15.1% | 0.11% | -3.4% |
| Q2 2021 | $2,439,000 | +14.6% | 9,088 | -3.9% | 0.12% | +16.0% |
| Q1 2021 | $2,129,000 | +4.5% | 9,460 | +3.1% | 0.10% | -3.8% |
| Q4 2020 | $2,038,000 | -9.4% | 9,173 | -12.2% | 0.10% | -34.2% |
| Q3 2020 | $2,249,000 | +3.5% | 10,445 | -15.0% | 0.16% | -13.2% |
| Q2 2020 | $2,173,000 | +30.6% | 12,287 | +2.2% | 0.18% | -9.5% |
| Q1 2020 | $1,664,000 | -45.4% | 12,020 | -41.2% | 0.20% | +23.3% |
| Q4 2019 | $3,050,000 | +118.5% | 20,443 | +111.5% | 0.16% | -3.0% |
| Q3 2019 | $1,396,000 | +12.0% | 9,667 | +10.9% | 0.17% | +23.5% |
| Q2 2019 | $1,246,000 | -6.5% | 8,715 | -13.6% | 0.14% | -8.1% |
| Q1 2019 | $1,332,000 | +20.4% | 10,086 | -6.0% | 0.15% | +10.4% |
| Q4 2018 | $1,106,000 | -8.6% | 10,727 | -3.7% | 0.13% | 0.0% |
| Q3 2018 | $1,210,000 | +10.7% | 11,138 | +0.6% | 0.13% | 0.0% |
| Q2 2018 | $1,093,000 | -15.4% | 11,076 | -16.1% | 0.13% | -23.9% |
| Q1 2018 | $1,292,000 | -59.7% | 13,196 | -61.8% | 0.18% | -59.2% |
| Q4 2017 | $3,209,000 | -13.5% | 34,576 | -20.0% | 0.43% | -10.8% |
| Q3 2017 | $3,709,000 | -7.3% | 43,241 | -8.8% | 0.48% | -6.2% |
| Q2 2017 | $4,003,000 | -9.7% | 47,431 | -8.5% | 0.52% | -4.1% |
| Q1 2017 | $4,431,000 | +633.6% | 51,810 | +567.3% | 0.54% | +713.6% |
| Q4 2016 | $604,000 | -22.5% | 7,764 | -21.9% | 0.07% | -7.0% |
| Q3 2016 | $779,000 | +3.2% | 9,943 | +33.1% | 0.07% | +4.4% |
| Q2 2016 | $755,000 | +19.5% | 7,472 | +12.1% | 0.07% | +28.3% |
| Q1 2016 | $632,000 | +39.5% | 6,667 | +36.7% | 0.05% | +60.6% |
| Q4 2015 | $453,000 | -44.8% | 4,876 | -49.4% | 0.03% | +10.0% |
| Q3 2015 | $820,000 | +99.0% | 9,634 | +100.0% | 0.03% | +3.4% |
| Q2 2015 | $412,000 | +0.7% | 4,817 | 0.0% | 0.03% | +3.6% |
| Q1 2015 | $409,000 | -4.9% | 4,817 | -4.0% | 0.03% | -15.2% |
| Q4 2014 | $430,000 | +12.9% | 5,017 | 0.0% | 0.03% | +6.5% |
| Q3 2014 | $381,000 | -5.7% | 5,017 | -2.2% | 0.03% | -8.8% |
| Q2 2014 | $404,000 | -16.9% | 5,132 | -20.8% | 0.03% | -22.7% |
| Q1 2014 | $486,000 | +13.3% | 6,482 | +16.7% | 0.04% | +12.8% |
| Q4 2013 | $429,000 | -90.0% | 5,553 | -91.0% | 0.04% | -76.2% |
| Q3 2013 | $4,295,000 | +15.6% | 61,960 | +5.6% | 0.16% | +7.9% |
| Q2 2013 | $3,714,000 | – | 58,676 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |